Lymphoma, AIDS-Related clinical trials
The registry lists 25 studies for Lymphoma, AIDS-Related across more than 10 countries. 2 are recruiting or about to start. 13 of them are mainly about Lymphoma, AIDS-Related (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.
Get an email when these change. Save the Lymphoma, AIDS-Related studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Cancer Institute (NCI) (5) · AIDS Malignancy Consortium (3) · Cancer Research UK (1) · Genzyme, a Sanofi Company (1) · Case Comprehensive Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · He Huang (1) · Shanghai Public Health Clinical Center (1)
What is being tested here
Drugs under test in Lymphoma, AIDS-Related studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Rituximab | 0 | 0 | 7 |
| Etoposide | 0 | 0 | 4 |
| Cyclophosphamide | 0 | 0 | 2 |
| Doxorubicin | 0 | 0 | 2 |
| Prednisone | 0 | 0 | 2 |
| Vincristine | 0 | 0 | 2 |
| Epoetin Alfa | 0 | 0 | 2 |
| Cytarabine | 0 | 0 | 2 |
| Ibrutinib | 0 | 0 | 1 |
| Lenalidomide | 0 | 0 | 1 |
Drug classes tested here Alkylating agents 4 · Corticosteroids 3
Who these studies take
Of the 2 Lymphoma, AIDS-Related studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 2 (100%) | 2 (100%) |
Across all 25 studies, recruiting or not: 32% stop at 75 or younger and 20% at 65; 12% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 25 of 25. search them.
- Optimization of Antiretroviral Therapy in Patients With AIDS-Related LymphomaRecruitingNCT07727642Not applicable1 country
- A Registry Study on HIV-related LymphomaRecruitingNCT052311354 countries
- Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasActive, not recruitingNCT03220022Phase 11 country
- Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell LymphomaCompletedNCT02911142Phase 1/21 country
- Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCCompletedNCT055109082 countries
- EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV InfectionCompletedNCT00006436Phase 21 country
- Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesNo longer availableNCT02822495
- Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin LymphomaCompletedNCT01775475Phase 22 countries
- High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCTTerminatedNCT00858793Phase 1/21 country
- Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/LympholeukemiaStatus unknownNCT05340829Phase 11 country
- EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated LymphomaCompletedNCT00001563Phase 21 country
- A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's LymphomaCompletedNCT00002348Phase 21 country
- Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral TherapyCompletedNCT036908951 country
- Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System LymphomaCompletedNCT002263041 country
- High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High RiskCompletedNCT01045889Phase 21 country
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWithdrawnNCT00310128Phase 2
- Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWithdrawnNCT01769911Not applicable1 country
- A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARLCompletedNCT00799136Phase 21 country
- Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT007576141 country
- Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWithdrawnNCT00499668Not applicable
- Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's DiseaseCompletedNCT00003114Phase 21 country
- A Study of Patients With AIDS SyndromeCompletedNCT000011201 country
- A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of OrganochlorinesCompletedNCT000015711 country
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 21 country
- Gene Therapy in HIV-Positive Patients With Non-Hodgkin's LymphomaCompletedNCT00002221Phase 21 country